翻訳と辞書 |
George C. Prendergast : ウィキペディア英語版 | George C. Prendergast
George C. Prendergast, PhD (born 1961) is an American oncologist and molecular biologist, currently president and CEO of Lankenau Institute for Medical Research (LIMR);〔(【引用サイトリンク】title=The Lankenau Institute for Medical Research - George C. Prendergast, PhD )〕 CEO of LIMR Development, Inc. and LIMR Chemical Genomics Center; co-leader of the Program in Cancer Cell Biology & Signaling at Kimmel Cancer Center, Thomas Jefferson University;〔(Program in Cancer Cell Biology & Signaling, Kimmel Cancer Center, Thomas Jefferson University )〕 and editor-in-chief of ''Cancer Research''.〔(''Cancer Research'' Editorial Board ); ''(Cancer Research )''(, ) a journal of the (American Association for Cancer Research )〕〔(【引用サイトリンク】title=About ''Cancer Research'' - American Association for Cancer Research )〕 == Education and career == Born in Philadelphia, Pennsylvania in 1961, Prendergast graduated from the University of Pennsylvania in 1983 with a BA in Biochemistry. He earned an MS in molecular biophysics from Yale University in 1984 and a PhD in Molecular biology from Princeton University in 1989.After receiving his doctorate, Prendergast continued his research as an American Cancer Society postdoctoral fellow at the Howard Hughes Medical Institute at NYU Medical Center. Prendergast joined the Department of Cancer Research at Merck Research Laboratories as a staff scientist in 1991. In 1993, he returned to academic research at The Wistar Institute in Philadelphia, first as an assistant professor and later as an associate professor and assistant chair of the Tumor Biology Group. While at Wistar, in 1995, Prendergast was designated a Pew Scholar in the Biomedical Sciences.〔(【引用サイトリンク】title=Pew Scholars Directory - George C. Prendergast, Ph.D. )〕 In 1999, Prendergast left Wistar to become senior director of the Cancer Research Group at DuPont Pharmaceuticals Company. After the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb, Prendergast moved his groups at Wistar and DuPont to Lankenau Institute for Medical Research (LIMR) as a senior investigator in 2002. He was appointed president and CEO of LIMR in 2004,.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「George C. Prendergast」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|